Article Versions Notes

Hińcza K, Kowalik A, Pałyga I, Walczyk A, Gąsior-Perczak D, Mikina E, Trybek T, Szymonek M, Gadawska-Juszczyk K, Zajkowska K, et al. Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer? Cancers. 2020; 12(2):423. https://doi.org/10.3390/cancers12020423

Hińcza, Kinga, Artur Kowalik, Iwona Pałyga, Agnieszka Walczyk, Danuta Gąsior-Perczak, Estera Mikina, Tomasz Trybek, Monika Szymonek, Klaudia Gadawska-Juszczyk, Klaudia Zajkowska, and et al. 2020. "Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?" Cancers 12, no. 2: 423. https://doi.org/10.3390/cancers12020423

Hińcza, K., Kowalik, A., Pałyga, I., Walczyk, A., Gąsior-Perczak, D., Mikina, E., Trybek, T., Szymonek, M., Gadawska-Juszczyk, K., Zajkowska, K., Suligowska, A., Kuchareczko, A., Krawczyk, K., Kopczyński, J., Chrapek, M., Góźdź, S., & Kowalska, A. (2020). Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer? Cancers, 12(2), 423. https://doi.org/10.3390/cancers12020423